N
Nuwellis
CHF Solutions focuses on an innovative cardiac assist therapy to treat patients with heart failure and related conditions
About Nuwellis
Nuwellis, Inc. is a medical device company that specializes in developing and commercializing products for the treatment of fluid overload, a condition that affects patients with heart failure and other cardiac diseases. The company's flagship product is the Aquadex FlexFlow system, a minimally invasive device that removes excess fluid from the body. The Aquadex system is used in hospitals and other clinical settings to treat patients who are not responding to diuretic drugs.
Read full description
Nuwellis' business model is based on the sale of its Aquadex FlexFlow system and related disposable products. The company sells its products through a direct sales force in the United States and through a network of distributors in other countries. Nuwellis' target customers include hospitals, clinics, and other healthcare providers that treat patients with heart failure and other cardiac diseases.
At a glance
- Founded
- 1998
- Headquarters
- Eden Prairie, United States
- Listing
- IPO 2012
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
National Institutes of Health
Series B and later1 investor entered at this stage
- TVTalu Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Nuwellis on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nuwellis on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.